A Plus Biotechnology Co (ROCO:6918) Total Liabilities : NT$258.3 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is A Plus Biotechnology Co Total Liabilities?

A Plus Biotechnology Co's Total Liabilities for the quarter that ended in Dec. 2024 was NT$258.3 Mil.

A Plus Biotechnology Co's quarterly Total Liabilities declined from Jun. 2024 (NT$317.58 Mil) to Sep. 2024 (NT$231.73 Mil) but then increased from Sep. 2024 (NT$231.73 Mil) to Dec. 2024 (NT$258.27 Mil).

A Plus Biotechnology Co's annual Total Liabilities declined from Dec. 2022 (NT$296.71 Mil) to Dec. 2023 (NT$243.38 Mil) but then increased from Dec. 2023 (NT$243.38 Mil) to Dec. 2024 (NT$258.27 Mil).

A Plus Biotechnology Co Total Liabilities Historical Data

The historical data trend for A Plus Biotechnology Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

A Plus Biotechnology Co Total Liabilities Chart

A Plus Biotechnology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

157.99

361.91

296.71

243.38

258.27

A Plus Biotechnology Co Quarterly Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial						-	243.38	317.58	231.73	258.27

A Plus Biotechnology Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

A Plus Biotechnology Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	163.309	+	(94.016	+	0.944
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	258.3

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	1177.314	-	919.045
	=	258.3

A Plus Biotechnology Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	163.309	+	(94.016	+	0.944
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	258.3

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	1177.314	-	919.045
	=	258.3

A Plus Biotechnology Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of A Plus Biotechnology Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

A Plus Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN

Website

https://www.aplusbio.com

A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.

A Plus Biotechnology Co Headlines

No Headlines